Voxello, developer of communication solutions for impaired hospitalized patients, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the noddleTM, a pioneering solution that detects voluntary gestures in hospitalized patients who would otherwise be unable to communicate.
Richard Wieland has been appointed as a new member of the Company's Board of Directors effective January 1st 2017. Mr. Wieland will also serve as the interim Chief Financial Officer.
Mr. Wieland is a senior financial executive with a diversified Life Science business background with more than thirty-five years of business experience in both public and private companies. He completed over twenty capital transactions including two successful IPOs and eleven M&A transactions. Subsequent to the M&A transactions, he successfully managed the post-acquisition integration programs.
The attendees of the critical care nursing were completely enthralled with Voxello's noddle. One of the attendees said: "I've gotten pretty good at reading lips from intubated patients, but this is much better." Imagine the frustration of nursing when they cannot communicate with their patients effectively, not to mention the anxiety of the patients. At Voxello, we aim to eliminate this problem.
3 River Venture Fair offers a unique opportunity to "speed date" with investors. It was a great 2 day event. On the first evening they did something a little more traditional called: Pitchburgh. It was a 2 minute Pitch to the audience and live streamed. Our CEO, Rives Bird, talks about Voxello.
With an anticipated launch this summer of its signature invention—a device that allows patients with physical impairments to communicate with hospital staff—University of Iowa spinout company Voxello continues to draw significant investor interest while clinical trials are underway.